Sunday, November 22, 2026

News, explained by people who know.

Money

Judge Approves Bayer’s $7.25 Billion Roundup Settlement Covering Current and Future Cancer Claims

A St. Louis judge granted final approval to Bayer’s nationwide class settlement of Roundup cancer claims, which will pay up to $7.25 billion over as many as 21 years to people diagnosed with non-Hodgkin lymphoma now and in the future.

By 3 min read
The illuminated Bayer Cross sign in Leverkusen, Germany
The Bayer Cross at the company’s home base in Leverkusen, Germany. H005, public domain, via Wikimedia Commons.

Nov. 22 (TodayViralUSA) — A Missouri judge has given final approval to Bayer’s settlement of lawsuits alleging its Roundup weed killer causes cancer, clearing the way for the German company to pay up to $7.25 billion over two decades and potentially ending litigation that has weighed on it for close to a decade.

St. Louis Circuit Judge Timothy Boyer found the nationwide class settlement “fair, reasonable, and adequate” in a ruling on Friday, describing the total as “among the largest in the history of mass tort personal-injury class action settlements.”

Who gets paid, and how much

The agreement covers people who have already been diagnosed with non-Hodgkin lymphoma, a blood cancer, as well as those diagnosed in future years. Bayer will make annual payments into a fund for up to 21 years.

Individual awards will vary widely. Agricultural, industrial or turf workers with long exposure who were diagnosed with an aggressive form of the disease before age 60 could receive an average of about $165,000, while people diagnosed at 78 or older would receive significantly less — an average of about $10,000, according to the Associated Press.

A ‘decisive milestone’ for Bayer

Bayer CEO Bill Anderson called the approval “a decisive milestone in the company’s strategy to mitigate the risks of both pending and future Roundup litigation.” Bayer has consistently denied that Roundup causes cancer, and its share price has fallen 46% since it acquired Roundup maker Monsanto in 2018, Reuters reported. The company had already paid roughly $10 billion to resolve earlier claims.

Plaintiffs’ attorney Christopher Seeger said the order “delivers guaranteed compensation to Roundup cancer victims who have waited more than a decade for justice.” Some lawyers, however, have argued the payouts are too small and the terms too restrictive; at a September hearing, attorney Gerson Smoger called it “the scariest, worst future settlement that’s ever been contemplated.”

Supreme Court ruling shifted the landscape

The deal was reached amid growing legal uncertainty for plaintiffs. In June, the U.S. Supreme Court ruled that Bayer cannot be sued in state courts for failing to warn about cancer, because federal regulations do not require such a label and states cannot impose additional labeling requirements.

The science remains contested. The World Health Organization’s cancer research agency classified glyphosate, Roundup’s active ingredient, as “probably carcinogenic” in 2015, while the Environmental Protection Agency has concluded it is not likely to cause cancer when used as directed. Bayer has removed glyphosate from new Roundup products sold to residential users, though it remains in agricultural use. About 200,000 Roundup-related claims have been filed against the company.

Sources & Credits

Image: The illuminated Bayer Cross in Leverkusen, Germany. H005, public domain, via Wikimedia Commons.

We are committed to accuracy. Editorial Standards · Report a correction

Join the conversation

Leave a Reply

Your email address will not be published. Required fields are marked *

The Morning Viral

The day's biggest stories plus one expert take, in your inbox every morning.

Get notified at launch

No spam. Unsubscribe anytime. Privacy Policy